Skip to content

Clinical study on the application of ginger combined with P6 acupressure in nausea and vomiting of neoplasm chemotherapy patients

Clinical study on the application of ginger combined with P6 acupressure in nausea and vomiting of neoplasm chemotherapy patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006604
Enrollment
Unknown
Registered
2022-09-15
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neoplasm

Interventions

ginger group:On the basis of the control group, two ginger capsules (each capsule contains 250mg ginger powder) were taken orally 30 minutes before chemotherapy, twice a day, once at breakfast and onc
P6 acupressure group:On the basis of the control group, P6 acupressure 10 minutes 30 minutes before chemotherapy, alternately on both sides, each side for 5 minutes, once a day
ginger and P6 acupressure group:On the basis of the control group, ginger and Neiguan point pressing were used at the same time,
control group:Routine treatment and comprehensive treatment

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Diagnosed as malignant tumor by imaging or histopathology; ? Have received chemotherapy and have experienced chemotherapy-related nausea and vomiting; ? Those who received high emetic chemotherapeutic drugs containing oxaliplatin combined with chemotherapy regimen; ? 18 years old and above; ? KPS score greater than 70; ? Informed consent and good compliance.

Exclusion criteria

Exclusion criteria: ? Vomiting caused by digestive tract obstruction, high intracranial pressure and other reasons; ? Those who received radiotherapy before and after chemotherapy; ? Nausea and vomiting occurred 24 hours before chemotherapy; ? People who are allergic to ginger or have dietary contraindications; ? Suffering from mental illness, infectious disease or sensitive skin; ? Poor compliance.

Design outcomes

Primary

MeasureTime frame
Nausea and vomiting;Perceived Benefit from illness; Nausea and vomiting Life Function Index;

Secondary

MeasureTime frame
treatment satisfaction scale;

Countries

China

Contacts

Public ContactQian Weiwei
373225219@qq.com13813292765

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026